about
General Practitioner Antimicrobial Stewardship Programme Study (GAPS): protocol for a cluster randomised controlled trialVancomycin therapeutics and monitoring: a contemporary approach.Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.A mixed methods study of the barriers and enablers in implementing antimicrobial stewardship programmes in Australian regional and rural hospitals.Australia-wide Point Prevalence Survey of Antimicrobial Prescribing in Neonatal Units: How Much and How Good?Australia-wide point prevalence survey of the use and appropriateness of antimicrobial prescribing for children in hospital.Antimicrobial stewardship activities: a survey of Queensland hospitals.Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen.Hematological reference ranges in black very low birth weight infants.A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country.Combination antibiotic therapy for Pseudomonas aeruginosa bacteremia in febrile neutropenic patients? The question still remains.An underutilised resource for Antimicrobial Stewardship: a 'snapshot' of the community pharmacists' role in delayed or 'wait and see' antibiotic prescribing.Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.The Impact of an Infectious Diseases Consultation on Antimicrobial PrescribingFosfomycin: what was old is new againComparing the delivery of albuterol metered-dose inhaler via an adapter and spacer device in an in vitro infant ventilator lung modelEvaluating the delivery of nebulized and metered-dose inhalers in an in vitro infant ventilator lung modelOptimising antimicrobial therapy through the use of Bayesian dosing programs
P50
Q35995327-5DBDC221-5C69-48E1-9CEF-105225CA1ABBQ38062923-7830CB6F-7EA6-485D-A414-6E0F5151BBAAQ38870252-60FAF1F7-0867-4C32-8D3F-0F572C63536DQ40830215-874044CB-50B1-4E5C-95F7-07F891DDB7E4Q40952678-7337D887-6B4C-4BDA-B8D6-7BA0485BF1F9Q41606037-94CBFE90-0CE1-4C54-8F87-D0FF43069282Q41673496-90886476-0E26-462B-9A73-154B2F505DECQ44286754-1895DBCF-9E21-4F79-A032-19AFA99249A8Q46616396-9B2D5F38-A6C3-4CA7-8B38-E0C5DA9B3DA6Q46677199-1388CD56-B5DB-49D4-8F3A-74C08632E06BQ48181412-58B2B762-3E49-4A02-96A2-61D18CAF0386Q48273264-2A482B07-6BE9-474E-8BF7-1A5B14EDB54CQ51532611-14F87133-D46E-4583-82C2-B8852C7A904CQ60231316-49664E1A-6695-4717-A797-E4A2C3560B15Q63859692-8C10CD24-4A23-45C7-BF6B-DC68A5761422Q74619012-F3B86A2B-A5B6-4F68-AFA3-BB806BFB4DCDQ74619015-A969FC0E-C4E2-4A7E-B26C-CB592F0D1BE3Q92490328-50024BF1-B19D-4246-8DF1-1B08F74ACC6D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Minyon Avent
@ast
Minyon Avent
@en
Minyon Avent
@es
Minyon Avent
@nl
Minyon Avent
@sl
type
label
Minyon Avent
@ast
Minyon Avent
@en
Minyon Avent
@es
Minyon Avent
@nl
Minyon Avent
@sl
prefLabel
Minyon Avent
@ast
Minyon Avent
@en
Minyon Avent
@es
Minyon Avent
@nl
Minyon Avent
@sl
P1053
C-9999-2011
P106
P1153
6602601124
P31
P3829
P496
0000-0001-7228-2834